Evidence map›Paper›PMID 35798962›Full record

ArticleAbdominal radiology (New York)2022

Accurate staging of non-metastatic colon cancer with CT: the importance of training and practice for experienced radiologists and analysis of incorrectly staged cases.

S van de Weerd, E Hong, I van den Berg, J W Wijlemans, J van Vooren, M W Prins, F J Wessels, B C Heeres, S Roberti, J Nederend and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Abdominal radiology (New York), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

S van de Weerd *Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0001-8145-8651
E Hong *Department of Radiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
I van den BergDepartment of Surgery, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
J W WijlemansDepartment of Radiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
J van VoorenDepartment of Radiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
M W PrinsDepartment of Radiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
F J WesselsDepartment of Radiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
B C HeeresDepartment of Radiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
S RobertiDepartment of Epidemiology and Biostatistics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
J NederendDepartment of Radiology, Catharina Hospital, Eindhoven, The Netherlands.
J H J M van KriekenDepartment of Pathology, Radboud University Medical Centre, Nijmegen, The Netherlands.
J M L RoodhartDepartment of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
R G H Beets-TanDepartment of Radiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
J P MedemaLaboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. j.p.medema@amsterdamumc.nl.
Utrecht University · NLRadboud University Nijmegen · NLThe Netherlands Cancer Institute · NLOncode Institute · NLSeoul National University Hospital · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo investigate whether locoregional staging of colon cancer by experienced radiologists can be improved by training and feedback to minimize the risk of over-staging into the context of patient selection for neoadjuvant therapy and to identify potential pitfalls of CT staging by characterizing pathologic traits of tumors that remain challenging for radiologists.

methodsForty-five cases of stage I-III colon cancer were included in this retrospective study. Five experienced radiologists evaluated the CTs; 5 baseline scans followed by 4 sequential batches of 10 scans. All radiologists were trained after baseline scoring and 2 radiologists received feedback. The learning curve, diagnostic performance, reader confidence, and reading time were evaluated with pathologic staging as reference. Pathology reports and H&E slides of challenging cases were reviewed to identify potential pitfalls.

resultsDiagnostic performance in distinguishing T1-2 vs. T3-4 improved significantly after training and with increasing number of reviewed cases. Inaccurate staging was more frequently related to under-staging rather than over-staging. Risk of over-staging was minimized to 7% in batch 3-4. N-staging remained unreliable with an overall accuracy of 61%. Pathologic review identified two tumor characteristics causing under-staging for T-stage in 5/7 cases: (1) very limited invasive part beyond the muscularis propria and (2) mucinous composition of the invading part.

conclusionThe high accuracy and specificity of T-staging reached in our study indicate that sufficient training and practice of experienced radiologists can ensure high validity for CT staging in colon cancer to safely use neoadjuvant therapy without significant risk of over-treatment, while N-staging remained unreliable.

Indexed as

Colonic NeoplasmsHumansNeoplasm StagingRadiologistsRetrospective StudiesSensitivity and SpecificityTomography, X-Ray ComputedColon cancerComputed tomographyLearning curveNeoadjuvant therapyRadiology

Identifiers

PMID35798962
PMCPMC9463303
OpenAlexW4284894087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.